A systematic review of method development and validation for ramipril analysis using HPLC in cardiovascular research

The field of analytical chemistry comprises many methodologies that are essential in ascertaining the chemical makeup of various substances. This review centers on two widely used techniques: high-performance liquid chromatography (HPLC) and UV-visible spectroscopy. By measuring absorbance using the Beer-Lambert rule, UV-visible spectroscopy can reveal the concentration of absorbing species. It is based on how light and matter interact, with absorption taking place as a result of molecular electronic transitions. HPLC, on the other hand, uses high pressure to separate mixture components according to how well they bind to a stationary phase. Its versatility is attributed to a number of different separation methods, including adsorption, partition, ion exchange, and size exclusion chromatography. In order to guarantee the dependability of analytical techniques, method development and validation are essential. It is necessary to evaluate validation factors, including specificity, accuracy, precision, linearity, and robustness, to ensure that a method is appropriate for the purpose for which it is intended. An analysis of the literature reveals various HPLC techniques for the analysis of ramipril, an ACE inhibitor used to treat heart failure and hypertension. These investigations have examined a range of mobile phases and columns, demonstrating the flexibility of HPLC in pharmaceutical analysis. By blocking the renin-angiotensin-aldosterone system (RAAS), ramipril works by decreasing inflammation and vasoconstriction. An extensive review of analytical chemistry techniques is given in this abstract, with special emphasis on the methods' significance for pharmaceutical analysis and drug development.